xmlinkhub
Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics | PLOS ONE
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms
Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study - The Lancet Digital Health
JCM | Free Full-Text | The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical Cancer
Disease-free Survival and Invasive-Disease-free Survival in the... | Download Scientific Diagram
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival | BMC Cancer | Full Text
Kaplan-Meier curves of disease-free survival (A), distant... | Download Scientific Diagram
View Image
Kaplan–Meier plots for disease-free survival (DFS) (A) and overall... | Download Scientific Diagram
Measures of Disease Frequency
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
Progression Free Survival
Value-Based Calculators in Cancer: Current State and Challenges | JCO Oncology Practice
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma | Journal for ImmunoTherapy of Cancer | Full Text
ANALYSIS OF SURVIVAL. The probability that an individual will survive (not die from) the cancer S URVIVAL M ORTALITY Probability of death from cancer. - ppt download
Disease-free survival curve (Kaplan Meier) associated with clusterin... | Download Scientific Diagram
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer | NEJM
Clinical Characteristics, Surgical Management, and Prognostic Factors of Medullary Thyroid Carcinoma: A Retrospective, Single-Center Study - Xin Wu, Binglu Li, Chaoji Zheng, 2022
Progression Free Survival
Disease Free Survival - an overview | ScienceDirect Topics
TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients | Aging
Measures of Disease Frequency
